House Dems Say FDA ‘Inappropriately Collaborated’ With Biogen on New Alzheimer’s Drug “I am hopeful these findings are a wake-up call for FDA to reform its practices and a call to action to my congressional colleagues to continue oversight of the pharmaceutical industry to ensure they don’t put profits over patients,” said Rep. Carolyn Maloney. Brett Wilkins Dec 30, 2022 Nearly two years after a leading U.S. consumer advocacy group sounded the alarm on the matter, House Democrats …Source
Related posts:
Big Pharma's contradictory JUNK SCIENCE: Merck pulls "promising" Alzheimer’s drug from tri...
U.S. House Unanimously Approves Sweeping Self-Driving Car Measure
Trump lashes Biden on White House stage, amid series of national crises
Going Underground – Ep. 594: John Bolton, Warmongering in the White House & EU Catalonian Politi...
Trump Sneaks Back Into White House By Dressing Up As Trans TikTok Star
Attack on free speech: House Democrats ignore First Amendment, issue letter to X (formerly Twitter) ...